MarketPeel
Insider Trading Intelligence
Pricing
…
SD

Scott Dreyer

COLL
EVP & CHIEF COMMERCIAL OFFICER · COLLEGIUM PHARMACEUTICAL, INC · CIK 0001746251
FILING MIX · LIFETIME29%/71%
BUYS
23
SELLS
56
TOTAL VALUE
$19.06M
COMPANIES
1
ACTIVE SINCE
Jan 2020
HOLDINGS NOW
71,770
AVG SELL PX
$33.09
TRADE KIND
SHOWING 79 / 79
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
31 backtested trades · 8 horizons · 21 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Scott Dreyer, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d31+51.61%-0.91%+0.44%-1.35%-0.83%-1.92
14d31+32.26%-1.22%+0.21%-1.43%+1.70%-1.31
30d31+74.19%-4.97%+0.40%-5.37%-3.13%-3.24
60d31+83.87%-6.63%+2.56%-9.18%-6.80%-4.67
90d31+70.97%-5.61%+4.56%-9.45%-7.43%—
180d31(2 pending)+65.52%-1.37%+12.01%-13.38%-19.45%—
1y31(6 pending)+36.00%+6.54%+19.75%-13.21%-8.38%—
2y31(13 pending)+22.22%+12.49%+35.28%-22.79%-27.96%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
COLL · 71,770 shares · as of Mar 3, 2026
047,53295,064142,595190,127202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
FLOW · 23 buys / 56 sellsCOVERAGE · 25 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
COLL
COLLEGIUM PHARMACEUTICAL, INC
SALE10b5-1
10b5-1 plan
46,417$40.36$1.87M75,329Mar 3, 2026Mar 5, 2026 ↗View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
SALE10b5-1
10b5-1 plan
3,559$40.99$145.9K71,770Mar 3, 2026Mar 5, 2026 ↗View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
SALE
EVP & Chief Commercial Officer
21,615$46.75$1.01M121,746Feb 10, 2026Feb 12, 2026 ↗View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
SALE
EVP & Chief Commercial Officer
9,977$46.75$466.4K143,361Feb 10, 2026Feb 12, 2026 ↗View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
PURCHASEGRANT
Stock grant
30,702——153,338Feb 10, 2026Feb 12, 2026 ↗View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
PURCHASEGRANT
Stock grant
19,023——122,636Feb 10, 2026Feb 12, 2026 ↗View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
PURCHASE
EVP & Chief Commercial Officer
17,600$15.90$279.8K121,213Dec 8, 2025Dec 10, 2025 ↗View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
SALE10b5-1
10b5-1 plan
11,125$47.89$532.8K110,088Dec 8, 2025Dec 10, 2025 ↗View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
SALE10b5-1
10b5-1 plan
6,475$48.66$315.1K103,613Dec 8, 2025Dec 10, 2025 ↗View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
SALE
EVP & Chief Commercial Officer
17,600——0Dec 8, 2025Dec 10, 2025 ↗View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
PURCHASE
EVP & Chief Commercial Officer
16,389$21.34$349.7K120,002Aug 18, 2025Aug 20, 2025 ↗View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
SALE
EVP & Chief Commercial Officer
16,389——0Aug 18, 2025Aug 20, 2025 ↗View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
SALE10b5-1
10b5-1 plan
16,389$38.21$626.2K103,613Aug 18, 2025Aug 20, 2025 ↗View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
PURCHASE
EVP & Chief Commercial Officer
4,861$21.34$103.7K108,474Aug 13, 2025Aug 15, 2025 ↗View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
SALE
EVP & Chief Commercial Officer
4,861——16,389Aug 13, 2025Aug 15, 2025 ↗View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
SALE10b5-1
10b5-1 plan
4,861$38.03$184.9K103,613Aug 13, 2025Aug 15, 2025 ↗View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
SALE10b5-1
10b5-1 plan
18,881$30.03$567.0K103,613Mar 21, 2025Mar 24, 2025 ↗View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
SALE10b5-1
10b5-1 plan
1,927$30.00$57.8K122,494Mar 20, 2025Mar 24, 2025 ↗View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
SALE10b5-1
10b5-1 plan
2,255$30.00$67.7K124,421Mar 14, 2025Mar 18, 2025 ↗View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
SALE10b5-1
10b5-1 plan
15,387$30.00$461.7K126,676Mar 11, 2025Mar 18, 2025 ↗View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
SALE10b5-1
10b5-1 plan
2,348$30.00$70.4K142,063Mar 7, 2025Mar 10, 2025 ↗View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
SALE10b5-1
10b5-1 plan
3,295$30.00$98.9K144,411Mar 6, 2025Mar 10, 2025 ↗View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
SALE10b5-1
10b5-1 plan
15,387$30.00$461.7K126,676Mar 6, 2025Mar 13, 2025 ↗View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
PURCHASEGRANT
Stock grant
26,411——177,329Feb 10, 2025Feb 12, 2025 ↗View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
SALE
EVP & Chief Commercial Officer
7,953$30.52$242.7K169,376Feb 10, 2025Feb 12, 2025 ↗View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
SALE
EVP & Chief Commercial Officer
21,670$30.52$661.4K147,706Feb 10, 2025Feb 12, 2025 ↗View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
PURCHASEGRANT
Stock grant
45,016——150,918Feb 10, 2025Feb 12, 2025 ↗View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
SALE
EVP & Chief Commercial Officer
56,807$33.98$1.93M105,902May 24, 2024May 28, 2024 ↗View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
PURCHASE
EVP & Chief Commercial Officer
23,791$24.03$571.7K162,709May 24, 2024May 28, 2024 ↗View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
SALE
EVP & Chief Commercial Officer
23,791——0May 24, 2024May 28, 2024 ↗View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
PURCHASE
EVP & Chief Commercial Officer
51,209$24.03$1.23M190,127May 23, 2024May 28, 2024 ↗View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
SALE
EVP & Chief Commercial Officer
51,209——23,791May 23, 2024May 28, 2024 ↗View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
SALE
EVP & Chief Commercial Officer
51,209$33.82$1.73M138,918May 23, 2024May 28, 2024 ↗View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
SALE10b5-1
10b5-1 plan
664$37.15$24.7K138,918Feb 26, 2024Feb 28, 2024 ↗View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
SALE10b5-1
10b5-1 plan
9,336$36.38$339.6K139,582Feb 26, 2024Feb 28, 2024 ↗View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
PURCHASEGRANT
Stock grant
35,000——146,322Feb 12, 2024Feb 14, 2024 ↗View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
SALE
EVP & Chief Commercial Officer
10,145$33.70$341.9K148,918Feb 12, 2024Feb 14, 2024 ↗View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
SALE
EVP & Chief Commercial Officer
19,545$33.70$658.7K159,063Feb 12, 2024Feb 14, 2024 ↗View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
PURCHASEGRANT
Stock grant
32,286——178,608Feb 12, 2024Feb 14, 2024 ↗View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
SALE10b5-1
10b5-1 plan
23,560$32.28$760.5K111,322Jan 16, 2024Jan 18, 2024 ↗View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
SALE
EVP & Chief Commercial Officer
13,324$26.70$355.8K134,882Mar 1, 2023Mar 3, 2023 ↗View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
PURCHASEGRANT
Stock grant
44,275——147,073Feb 10, 2023Feb 14, 2023 ↗View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
PURCHASEGRANT
Stock grant
22,459——169,532Feb 10, 2023Feb 14, 2023 ↗View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
SALE
EVP & Chief Commercial Officer
6,797$26.75$181.8K148,206Feb 10, 2023Feb 14, 2023 ↗View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
SALE
EVP & Chief Commercial Officer
14,529$26.75$388.7K155,003Feb 10, 2023Feb 14, 2023 ↗View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
SALE
EVP & Chief Commercial Officer
7,341$27.83$204.3K102,867Jan 9, 2023Jan 11, 2023 ↗View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
SALE
EVP & Chief Commercial Officer
69$28.58$2.0K102,798Jan 9, 2023Jan 11, 2023 ↗View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
SALE
EVP & Chief Commercial Officer
10,424$27.08$282.3K110,208Jan 9, 2023Jan 11, 2023 ↗View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
SALE
EVP & Chief Commercial Officer
594$17.48$10.4K120,632Jul 11, 2022Jul 13, 2022 ↗View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
SALE
EVP & Chief Commercial Officer
10,559$21.61$228.2K121,226Feb 18, 2022Feb 28, 2022 ↗View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
SALE
EVP & Chief Commercial Officer
6,643$17.63$117.1K135,801Feb 10, 2022Feb 14, 2022 ↗View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
PURCHASEGRANT
Stock grant
13,675——142,444Feb 10, 2022Feb 14, 2022 ↗View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
PURCHASEGRANT
Stock grant
52,500——128,769Feb 10, 2022Feb 14, 2022 ↗View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
SALE
EVP & Chief Commercial Officer
4,016$17.63$70.8K131,785Feb 10, 2022Feb 14, 2022 ↗View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
SALE
EVP & Chief Commercial Officer
701$19.05$13.4K76,269Jan 10, 2022Jan 12, 2022 ↗View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
SALE
EVP & Chief Commercial Officer
5,693$18.33$104.4K76,970Dec 15, 2021Dec 17, 2021 ↗View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
SALE
EVP & Chief Commercial Officer
595$23.17$13.8K82,663Jul 12, 2021Jul 14, 2021 ↗View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
SALE
EVP & Chief Commercial Officer
2,100$24.89$52.3K89,056Feb 11, 2021Feb 12, 2021 ↗View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
SALE
EVP & Chief Commercial Officer
5,798$25.33$146.9K83,258Feb 11, 2021Feb 12, 2021 ↗View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
SALE
EVP & Chief Commercial Officer
3,283$25.95$85.2K91,156Feb 10, 2021Feb 12, 2021 ↗View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
SALE
EVP & Chief Commercial Officer
1,901$25.95$49.3K94,439Feb 10, 2021Feb 12, 2021 ↗View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
PURCHASEGRANT
Stock grant
6,165——96,340Jan 19, 2021Jan 22, 2021 ↗View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
PURCHASEGRANT
Stock grant
45,780——90,175Jan 19, 2021Jan 22, 2021 ↗View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
PURCHASEGRANT
Stock grant
130,800——130,800Jan 19, 2021Jan 21, 2021 ↗View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
PURCHASEGRANT
Stock grant
45,780——90,175Jan 19, 2021Jan 21, 2021 ↗View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
PURCHASEGRANT
Stock grant
6,165——96,340Jan 19, 2021Jan 21, 2021 ↗View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
SALE
EVP & Chief Commercial Officer
1,322$22.89$30.3K44,395Jan 15, 2021Jan 20, 2021 ↗View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
SALE
EVP & Chief Commercial Officer
701$21.18$14.8K45,717Jan 11, 2021Jan 13, 2021 ↗View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
SALE
EVP & Chief Commercial Officer
1,429$17.01$24.3K46,418Jul 13, 2020Jul 14, 2020 ↗View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
SALE
EVP & Chief Commercial Officer
594$16.73$9.9K47,847Jul 10, 2020Jul 14, 2020 ↗View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
SALE
EVP & Chief Commercial Officer
8,000——17,600May 18, 2020May 20, 2020 ↗View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
SALE
EVP & Chief Commercial Officer
8,000$24.00$192.0K48,441May 18, 2020May 20, 2020 ↗View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
PURCHASE
EVP & Chief Commercial Officer
8,000$15.90$127.2K56,441May 18, 2020May 20, 2020 ↗View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
SALE
EVP & Chief Commercial Officer
4,434$22.61$100.3K48,441May 13, 2020May 15, 2020 ↗View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
SALE
EVP & Chief Commercial Officer
1,966$21.62$42.5K52,875Feb 10, 2020Feb 12, 2020 ↗View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
PURCHASEGRANT
Stock grant
19,125——54,841Feb 5, 2020Feb 7, 2020 ↗View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
PURCHASEGRANT
Stock grant
21,250——21,250Feb 5, 2020Feb 7, 2020 ↗View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
SALE
EVP & Chief Commercial Officer
1,321$23.87$31.5K35,716Jan 14, 2020Jan 16, 2020 ↗View →
COLL
COLLEGIUM PHARMACEUTICAL, INC
SALE
EVP & Chief Commercial Officer
702$23.30$16.4K37,037Jan 10, 2020Jan 14, 2020 ↗View →
Other insiders · COLL
Loading peer insiders…
About this filer
CIK 0001746251
ROLE
EVP & Chief Commercial Officer
PRIMARY
COLL
COMPANIES
1
ACTIVE SINCE
Jan 2020
MARKETPEEL · /INSIDER/0001746251DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback